Biotech and Money London Adds Pharma Forum Day to Help UK Life Science Companies Assess Partnership Potential with Big Pharma
London, UK, 17th December 2015 / Sciad Newswire / Biotech and Money London, a C-level executive conference that helps build linkages and business opportunities for UK life science companies taking place on 2-3 February 2016, has added a Pharma Forum Day to help UK life science Executives assess collaboration opportunities with many of the industry’s Big Pharma players.
Recognising the continued and growing importance of business development and licensing, partnerships and M&A opportunities for the UK science base, the conference is presenting sessions for major Pharma and Big Biotech BD heads to promote their external partnering and business development opportunities in their areas of disease leadership.
Companies already signed up to participate in the Pharma Forum Day includes Lilly, AstraZeneca, GSK, Pfizer, Novartis, EMD Serono, Sanofi and Ipsen Biopharm. With a total of 10 slots being offered up on the 3rd February.
The 2nd annual Biotech and Money London conference, hosted together with prominent partners EY, Lilly, Nasdaq, Covington & Burling and Panmure Gordon, will bring together over 300 of the finest names in the sector to discuss the strategies to successfully raising finance and investment, the means to building a strong and sustainable capital market in the UK and the opportunities around building long term partnerships and collaborations with the industry’s key players.
With a focus on quality peer-2-peer discussion, high level networking and partnering, unique formats and a vetted, high calibre audience, the event attracts the people that matter to the future of life science investment and deal making.
Terry O’Dwyer, Co-CEO, Biotech and Money, said: “Recognising that funding and investment is only one piece of the puzzle for life science companies, adding the Pharma Forum Day allows innovative UK science to hear from and meet prospective partners who are aligned with specific disease areas, to help maximise their chances of deal making. We’re excited at the dynamic this will create alongside our traditional investment content on day one.”
To view the full event programme and register, please visit http://biotechandmoney.com/biotechandmoneylondon2016 or call +44 (0) 207 193 9664. Alternatively, keep up to date with the event on Twitter @BiotechandMoney or using #BMLDN2016.
About Biotech and Money London
The Biotech and Money London 2016 conference takes place on 2-3 February 2016 at etc.Venues in London. The event is a two-day congress providing the education, strategies and solutions life science companies need to enable more effective funding, investment, business planning and partnering within their businesses. The conference is co-located with HealthEx London, an invite only closed door Chatham House Rules Listed Forum for CEOs, CFOs, Chairmen and NEDs of publicly listed companies.
About Biotech and Money
Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Visit www.biotechandmoney.com.
For media information please contact
Tel: +44 (0) 207 193 9664
Got an innovation you need bringing to life?
We’d love to hear from you! Head to our contact page to start a conversation.